share_log

万邦德:关于子公司WP103药品临床试验申请获得 FDA 受理的公告

Wan Bond: Announcement on the acceptance of the subsidiary WP103 drug clinical trial application by the FDA

SZSI ·  Dec 17, 2024 08:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more